In collaboration with
11
4th International Forum
INNOVATION in PSYCHIATRY
New Clinical and Bio-Pathogenetic
Models in Psychopathology.
Implications for Treatment
PROGRAMME
Under the Patronage of:
9 -11 May 2011
DEGLI
UNIVERSITÀ
STUDI DI MILANO
DI
FACOLTÀ
MEDICINA E CHIRURGIA
MILANO
Fiera Milano
Congressi S.p.a.
via Gattamelata, 5
Assessorato
alla Salute
Società Italiana
di Psicopatologia
Società Italiana
di Neuropsicofarmacologia
“in Memoria“
del Prof. Carlo Lorenzo Cazzullo
INNOPSY 11
New Clinical and Bio-Pathogenetic
Models in Psychopathology.
Implications for Treatment
Presentation
9 -11 May 2011
MILANO
11
New Clinical and Bio-Pathogenetic
Models in Psychopathology.
Implications for Treatment
INNOPSY is an International Forum that is held in
Milan biennially focused on innovative aspects of
clinical diagnosis, management and treatment of
Major Psychoses and Anxiety Disorders sponsored
among others by World Federation of Societies of
Biological Psychiatry (WFSBP) and International
Society for Bipolar Disorders (ISBD).
The fourth Edition will deal with clinical biological
models possibly involved in the pathogenesis of
these disorders and their implications for
treatment. The various topics will be presented by
international clinical researchers with established
competence in the field of neurochemistry,
genetics, neuroimaging and neurocognition of
Schizophrenia, Mood and Anxiety Disorders.
As usual the Forum is structured with Main Lectures
and Plenary Sessions, Meet the Expert, Satellite
Sponsored Symposia and a Poster Session. In this
edition will be also a Joint Workshop with the
International Society for Bipolar Disorders (ISBD).
As during the previous Editions young scientists are
particularly welcomed to actively participate at the
Forum presenting their own original research in the
Poster Session and a dedicated jury will award the
best contributions.
9 May Monday
08.30-09.20
Opening Ceremony
09.20-09.30 Introduction to the topic of the Congress
A.C. Altamura (I)
Lectures:
Chairmen: A.C. Altamura (I), M. Maj (I)
09.30-10.00 The bipolar spectrum as a pathophysiologic
model: temperaments and the search for genes
H. Akiskal (USA)
10.00-10.30 PCP/NMDA model of Schizophrenia
D.C. Javitt (USA)
10.30-11.00 Coffee break
11.00-12.00 Satellite Symposium
Chairman: A.C. Altamura (I)
Neurochemical model of Depression in relation
to outcome and remission
The neurobiological validation of common
psychiatric diagnoses, is there hope?
H. Agren (S)
The goals of Depression treatment: symptoms
remission and return to normal levels of
functionality
A. Troisi (I)
In collaboration with Eli Lilly
12.00-12.45 Meet the Expert
Chairman: G. Racagni (I)
Challenges in the long-term treatment of
Schizophrenia - Linking evidence to real-life
clinical care
S. Kapur (UK)
In collaboration with Eli Lilly
12.45-13.30 Meet the Expert
Chairman: M. Maj (I)
Bipolar Mania - Understanding and treatment
S. Kasper (A)
In collaboration with Pfizer Italia
13.30-14.30 Lunch
9 -11 May 2011
MILANO
11
Plenary Session:
SCHIZOPHRENIA
Chairmen: A. Rossi (I), E. Sacchetti (I), E. Smeraldi (I)
14.30-15.00 Dimensional model for Schizophrenia and
implications for treatment
H. Meltzer (USA)
15.00-15.30 The past, present and future role of the
dopamine D2 receptor in Schizophrenia
S. Kapur (UK)
15.30-16.00 Validity of the dimensional model in relation to
the pharmacological Guidelines
P. Falkai (D)
16.00-16.15 Discussant: A. Rossi (I)
16.15-16.45 Coffee break
16.45-17.45 Satellite Symposium
Chairman: A.C. Altamura (I)
From acute treatment to the maintenance in
Schizophrenia
Efficacy of Paliperidone in Acute
Schizophrenia: from clinical data to real world
H. Meltzer (USA)
Long term effectiveness
E. Sacchetti (I)
In collaboration with Janssen
17.45-18.45 Inaugural Reception
programme
10 May Tuesday
08.00-09.00 CME Course
room orange
What clinical features should determine
treatment of Severe Depression?
G. Goodwin (UK)
In collaboration with Lundbeck Italia
Plenary Session:
BIPOLAR DISORDER
Chairmen: G.B. Cassano (I), S. Scarone (I)
09.00-09.30 Dopamine and oxidative stress connection for
Bipolar Disorder
L. Yatham (CAN)
09.30-10.00 Neuroimaging studies of cognition in Bipolar
Disorder
S. Frangou (UK)
10.00-10.15 Discussant: P. Brambilla (I)
10.15-10.45 Coffee break
10.45-11.45 Satellite Symposium
Chairman: A.C. Altamura (I)
Advancing the treatment of Depression
beyond ADs
Burden of Depressive Disorder:
unipolar or bipolar?
G. Goodwin (UK)
Discussant: B. Dell'Osso (I)
In collaboration with AstraZeneca
11.45-12.30 Meet the expert
Bipolar Disorder and management of mania
M. Tohen (USA)
In collaboration with Lundbeck Italia
12.30-13.00 Karla R. Dougherty: a journalist’s experience on
Bipolar Disorder
13.00-14.00 Lunch
9 -11 May 2011
MILANO
14.00-14.45 Meet the expert
Chairman: A.C. Altamura (I)
Critical review of Bipolar Guidelines
A. Fagiolini (I)
11
In collaboration with Bristol-Myers Squibb
JOINT WORKSHOP WITH THE INTERNATIONAL SOCIETY
FOR BIPOLAR DISORDERS (ISBD)
Chairmen: A.C. Altamura (I), A. Siracusano (I)
14.45-17.15 New avenues in the diagnosis and treatment of
Bipolar Disorder
The diagnostic issue: an updating
G. Goodwin (UK)
Outcome and maintenance treatment
of Bipolar Disorder
M. Tohen (USA)
Novel therapies for Bipolar Disorder
M. Berk (AUS)
Psychoeducation: how important in Bipolar
Disorder
K. Dougherty (USA)
Discussant: M. Mauri (I)
17.15-19.00 Posters Display - Wine and cheese
programme
11 May Wednesday
08.00-09.00 CME Course
room orange
The pharmacological treatment of Anxiety
Spectrum Disorders
C. Allgulander (S)
In collaboration with Lundbeck Italia
09.00-10.00 Posters Awards
Chairmen: M. Bassi (I), B. Carpiniello (I)
10.00-11.00 Meet the Expert
Agomelatine: a new antidepressant profile.
From clinical data to daily practice
M. Mauri (I)
In collaboration with IFB Stroder
11.00-11.30 Coffee break
Plenary Session:
ANXIETY DISORDERS
Chairmen: G. Ba (I), F. Bogetto (I), C. Mencacci (I)
11.30-12.00 The neural basis of Impulsivity: what we can
learn from clinical studies
H. Berlin (USA)
12.00-12.30 Novel approaches to treatment of Generalized
Anxiety Disorder
C. Allgulander (S)
12.30-13.00 Discussant: M. Guazzelli (I)
13.00-14.30 General Discussion and Conclusions
Farewell Reception
9 -11 May 2011
MILANO
11
SPONSORS:
AstraZeneca
Bristol-Myers Squibb
Confcommercio Unione Imprese per l'Italia
Eli Lilly Italia
I. F. B. Stroder
Italfarmaco
Janssen Cilag
Lundbeck Italia
Pfizer Italia
Servier Italia
programme
general information
CME
The Congress will provide 4.20 CME credits.
CME credits will be garanted to Medical Doctors
specialized one of the following disciplines:
! Child Neuropsychiatry
! Psychiatry
! Neurology
! Pharmacology and Clinical Toxicology
In order to be assigned CME credits, participants
shall:
! be fully registered for Congress attendance
! attend 80% of the event (beginning May 9th at
th
8.30 a.m. and closing May 11 at 2.30 p.m.):
! be sharply on time at the beginning of each
session (the presence of each participant will
be checked via an electronic reporting system)
! return to the Congress Secretariat all the ECM
documents filled in and signed
! after the Congress, CME credit certificates will
be sent by mail to the address indicated by
participants on registration form
Provider:
salute
comunicazione e ricerca per la salute
ID 329 - Codice ECM 329-3625
9 -11 May 2011
MILANO
11
Poster-Abstracts
Topic of submitted abstracts should be related to
congress main areas.
Once accepted, a selected Jury will award with a Price
the six best posters. The awards consist of a grant of
€ 800 for the first, € 600 for the second, € 450 for the
third and € 300 for the others.
Only the top three posters will be selected for oral
presentation during the “Poster Award” Session.
programme
11
Chairman
Alfredo Carlo Altamura
Scientific Secretariat
Elisabetta Cattaneo
Bernardo Dell'Osso
Massimiliano Buoli
Clinica Psichiatrica
Università degli Studi di Milano
Dipartimento di Salute Mentale
Ospedale Maggiore Policlinico
Via F. Sforza 35
20122 Milano
Tel.: +39-02-55035982
Fax: +39-02-55035952
E-mail:
[email protected]
Scientific Committee
Giovanni Biggio
Massimo Biondi
Filippo Bogetto
Bernardo Carpiniello
Massimo Casacchia
Giovanni B. Cassano
Filippo Drago
Carlo Faravelli
Athanasios Koukopoulos
Mario Maj
Giovanni Muscettola
Gianfranco Placidi
Giorgio Racagni
Alessandro Rossi
Emilio Sacchetti
Silvio Scarone
Alberto Siracusano
Enrico Smeraldi
Congress Secretariat
Viale G. Mazzini, 145
00195 Roma, Italia
Tel. +39 06398651 r.a.
Fax +39 0639730337
E-mail: [email protected]
www.mgacongressi.it
salute
comunicazione e ricerca per la salute ID 329 Codice ECM 329-3625